Management of a Type I Hypersensitivity Reaction to IV Etoposide in a Woman with a Yolk Sac Tumor: A Case Report

• Hauptverfasser: David Starks (Verfasst von), Deborah Prinz (Verfasst von), Amy Armstrong (Verfasst von), Lindsay Means (Verfasst von), Steven Waggoner (Verfasst von), Robert DeBernardo (Verfasst von)
• Format: Buch
• Veröffentlicht: Hindawi Limited, 2011-01-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Type I hypersensitivity reactions to intravenous administration of etoposide are extremely rare. Etoposide is an essential component of several chemotherapy regimens used in gynecologic oncology, and discontinuation of this drug during a course of treatment should only be due to severe patient intol...